New Cancer Model Shows Genomic Link Between DCIS and IDC Breast Cancer Types
A new genetic-based model may explain how ductal carcinoma in situ (DCIS) progresses to a more invasive form of cancer, say researchers at The University of Texas MD Anderson Cancer Center. The study provides new insight into how DCIS leads to invasive ductal carcinoma (IDC) and provides a clearer understanding of why some of these cancers go undetected. Findings were published by Casasent et al in Cell. The discovery was made possible by the researchers’ development of a new analytic tool called topographic single-cell sequencing (TSCS).
“While DCIS is the most common form of early-stage breast cancer and is often detected during mammography, 10% to 30% of this type of cancer progresses to IDC,” said Nicholas Navin, PhD, Associate Professor of Genetics at MD Anderson. “Exactly how DCIS invasion occurs genomically remains poorly understood due to several technical challenges in tissue analysis.”
The problem lies within the tumor itself, with cells that often have individual genetic characteristics, known as intratumor heterogeneity. Their unique cellular makeup makes treatment more difficult, while a low number of tumor cells in the breast milk ducts make the cells harder to spot due to their scarcity.
Study Findings
Dr. Navin’s team found that genome evolution occurs in the ducts before cancer clones can be disseminated by “breaking through” the thin layer of tissue known as the basement membrane. They found that multiple cancer cell clones comigrate from the ducts into adjacent regions to form invasive tumors.
Previous single-cell DNA sequencing methods have emerged as powerful tools for understanding intratumor heterogeneity, but they delete information about individual tumor cells’ precise location within the tissue. Cellular spatial data is critical for knowing whether tumor cells are DCIS or IDC. TSCS more accurately measures and describes specific characteristics of single tumor cells.
“Because TSCS provides spatial information on cell location, it represents a milestone over previous methods that can only use suspension of cells, therefore losing all spatial information,” said Dr. Navin. “We hypothesized that invasive cells share a direct genomic lineage with one or more single cells in the ducts,” he said. “Our data revealed a direct genomic lineage between both DCIS and IDC and further showed that most mutations and DNA copy number aberrations evolved within the ducts, prior to invasion.”
To arrive at these findings, Dr. Navin’s team used exome sequencing and applied TSCS to 1,293 single cells from 10 patients with both DCIS and IDC.
“TSCS and other similar single-cell sequencing methods hold great potential for opening new avenues of investigation in early-stage cancers,” said Dr. Navin. “It is our hope that this type of study will shed light on the enigmatic question of why some premalignant cancers do not progress, while others become invasive.”
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.
